Hyperthermic intraperitoneal chemotherapy with oxaliplatin—Still not the standard of care for patients with colorectal peritoneal metastases

Podobne zapisy

• Reply to ‘Hyperthermic intraperitoneal chemotherapy with oxaliplatin—Still not standard of care for patients with colorectal peritoneal metastases’ by Julianov and Saroglu
  od: de Jong, Loek A.W., i wsp.
  Wydane: (2019)
• Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer
  od: Spiegelberg, Julia, i wsp.
  Wydane: (2020)
• Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy
  od: Ubink, I., i wsp.
  Wydane: (2019)
• The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
  od: Wong, Jolene Si Min, i wsp.
  Wydane: (2020)
• Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases
  od: Mirnezami, Reza, i wsp.
  Wydane: (2014)